Literature DB >> 27240883

Using machine learning to model dose-response relationships.

Ariel Linden1,2, Paul R Yarnold3,4, Brahmajee K Nallamothu5.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Establishing the relationship between various doses of an exposure and a response variable is integral to many studies in health care. Linear parametric models, widely used for estimating dose-response relationships, have several limitations. This paper employs the optimal discriminant analysis (ODA) machine-learning algorithm to determine the degree to which exposure dose can be distinguished based on the distribution of the response variable. By framing the dose-response relationship as a classification problem, machine learning can provide the same functionality as conventional models, but can additionally make individual-level predictions, which may be helpful in practical applications like establishing responsiveness to prescribed drug regimens.
METHOD: Using data from a study measuring the responses of blood flow in the forearm to the intra-arterial administration of isoproterenol (separately for 9 black and 13 white men, and pooled), we compare the results estimated from a generalized estimating equations (GEE) model with those estimated using ODA.
RESULTS: Generalized estimating equations and ODA both identified many statistically significant dose-response relationships, separately by race and for pooled data. Post hoc comparisons between doses indicated ODA (based on exact P values) was consistently more conservative than GEE (based on estimated P values). Compared with ODA, GEE produced twice as many instances of paradoxical confounding (findings from analysis of pooled data that are inconsistent with findings from analyses stratified by race).
CONCLUSIONS: Given its unique advantages and greater analytic flexibility, maximum-accuracy machine-learning methods like ODA should be considered as the primary analytic approach in dose-response applications.
© 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adherence; data mining; dose-response; efficacy; machine learning

Mesh:

Substances:

Year:  2016        PMID: 27240883     DOI: 10.1111/jep.12573

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  4 in total

Review 1.  Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.

Authors:  Omer Adir; Maria Poley; Gal Chen; Sahar Froim; Nitzan Krinsky; Jeny Shklover; Janna Shainsky-Roitman; Twan Lammers; Avi Schroeder
Journal:  Adv Mater       Date:  2019-07-09       Impact factor: 30.849

Review 2.  Machine Learning in Causal Inference: Application in Pharmacovigilance.

Authors:  Yiqing Zhao; Yue Yu; Hanyin Wang; Yikuan Li; Yu Deng; Guoqian Jiang; Yuan Luo
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

3.  Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.

Authors:  Tina Kiguradze; William H Temps; Steven M Belknap; Paul R Yarnold; John Cashy; Robert E Brannigan; Beatrice Nardone; Giuseppe Micali; Dennis Paul West
Journal:  PeerJ       Date:  2017-03-09       Impact factor: 2.984

4.  Discrimination of DNA Methylation Signal from Background Variation for Clinical Diagnostics.

Authors:  Robersy Sanchez; Xiaodong Yang; Thomas Maher; Sally A Mackenzie
Journal:  Int J Mol Sci       Date:  2019-10-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.